Nuwellis Expands Pediatric Care with New Hospital Partnership
Nuwellis, Inc. (Nasdaq: NUWE), a pioneering medical technology firm focused on improving the quality of life for individuals experiencing fluid overload, has announced an impactful collaboration with a prestigious pediatric hospital in Utah. This partnership marks the company's 44th account dedicated to pediatric care, emphasizing Nuwellis' commitment to addressing the complexities associated with fluid management in young patients.
Innovative Therapy for Pediatric Patients
The pediatric hospital will integrate the Aquadex SmartFlow® system into its treatment protocols to assist children suffering from fluid overload due to kidney and heart ailments. With the growing number of pediatric patients facing these health challenges, this partnership presents an opportunity to deliver advanced therapy that focuses on highly individualized fluid management strategies.
Transformative Solutions for Vulnerable Patients
Fluid overload can pose serious health risks for children grappling with severe medical conditions, making effective management crucial. The Aquadex SmartFlow® system serves as an ultrafiltration therapy device designed to safely and effectively remove excess fluid from the body, helping patients achieve fluid balance more comfortably and safely than traditional methods such as continuous renal replacement therapy (CRRT).
Leadership Insight on the Collaboration
Nuwellis President and CEO, Nestor Jaramillo, shared his enthusiasm regarding this new venture. He stated, "We feel privileged to partner with this top-tier children's hospital, renowned for its dedication to pediatric care. This partnership represents our ongoing efforts to expand our pediatric offerings and enhance care for children in need of advanced medical solutions. Our goal is to leverage innovative technologies like Aquadex to empower healthcare providers and deliver hope to families facing critical health challenges."
Addressing Fluid Management Challenges
Disease, injury, and surgical procedures often lead to fluid retention, which can complicate recovery. The Aquadex SmartFlow® system is uniquely positioned to address these challenges. It offers a clinically proven therapy that promises not only to reduce fluid overload but also helps stabilize patients in critical care settings.
Commitment to Expanding Access to Therapy
Nuwellis is devoted to improving access to the Aquadex SmartFlow® therapy for both pediatric and adult patients. By equipping healthcare providers with effective tools to manage fluid overload, Nuwellis is fostering an environment where patients can receive the compassionate care they deserve during their most vulnerable moments.
Your Partner in Health Innovation
As a dedicated medical device company, Nuwellis stands at the forefront of transforming treatment approaches for patients suffering from fluid overload through collaboration and innovation. Headquartered in Minneapolis, the company operates with a dedicated focus on advancing the Aquadex SmartFlow® system and ensuring its availability to healthcare facilities nationwide.
About the Aquadex SmartFlow® System
The Aquadex SmartFlow® system is designed to provide a safe and effective method for managing hypervolemia and is indicated for use in both adults and pediatric patients weighing 20 kg or more. This system not only enhances the quality of care but also reflects Nuwellis' commitment to patient-centered therapies that adapt to individual needs.
Frequently Asked Questions
What is the Aquadex SmartFlow® system?
The Aquadex SmartFlow® system is an ultrafiltration therapy device designed to remove excess fluid from patients suffering from fluid overload.
How does the partnership benefit pediatric patients?
This partnership provides advanced therapy options that tailor fluid management specifically for children, addressing their unique health challenges.
What are the indications for using the Aquadex SmartFlow® system?
The system is indicated for temporary or extended use in patients whose fluid overload is unresponsive to standard medical management.
Who administers the Aquadex therapy?
All treatments with the Aquadex SmartFlow® system are administered by healthcare professionals within a clinical setting, under physician supervision.
What is Nuwellis' commitment to healthcare innovation?
Nuwellis aims to enhance the lives of patients with fluid overload through innovative medical technologies and partnerships that broaden access to effective therapies.
